Wide Ranks

GUTS

Fractyl Health, Inc.

2.33

Top Statistics
Market Cap 112 M Forward PE -0.9137 Revenue Growth -61.10 %
Current Ratio 5.58 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.12 Enterprise / Revenue 931.32 Price To Sales Trailing12 Months 1155.37
Profitability
Profit Margins 0.00 % Operating Margins -169957.14 %
Balance Sheet
Total Cash 84 M Total Cash Per Share 1.76 Total Debt 62 M
Total Debt To Equity 125.06 Current Ratio 5.58 Book Value Per Share 1.05
All Measures
Short Ratio 467.00 % Message Board Id finmb_154091089 Shares Short Prior Month 1 M
Return On Equity -2.86 City Burlington Uuid 95a73452-3cae-389d-803e-eb9744c62ae7
Previous Close 2.17 First Trade Date Epoch Utc 1 B Book Value 1.05
Total Debt 62 M Volume 315788 Price To Book 2.23
Fifty Two Week Low 1.74 Total Cash Per Share 1.76 Total Revenue 97000
Shares Short Previous Month Date 1 B Target Median Price 15.50 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins -169957.14 % Target Mean Price 15.50
Net Income To Common -68971000 Short Percent Of Float 0.0804 Implied Shares Outstanding 48 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 340610
Average Volume10days 340610 Total Cash 84 M Next Fiscal Year End 1 B
Revenue Per Share 0.0030 Held Percent Insiders 0.0484 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 2.17
Target Low Price 13.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.45
Open 2.19 Free Cashflow -36660752 State MA
Dividend Yield 0.00 % Return On Assets -0.5532 Time Zone Short Name EST
Trailing Eps -1.58 Day Low 2.19 Address1 3 Van de Graaff Drive
Shares Outstanding 48 M Price Hint 4 Target High Price 18.00
Website https://fractyl.com 52 Week Change -0.8187 Average Volume 360165
Forward Eps -2.48 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 538.70 % Is_sp_500 False Regular Market Day High 2.38
Profit Margins 0.00 % Debt To Equity 125.06 Fifty Two Week High 14.50
Day High 2.38 Shares Short 1 M Regular Market Open 2.19
Industry Key biotechnology Earnings Growth 0.00 % Enterprise To Revenue 931.32
Revenue Growth -61.10 % Shares Percent Shares Out 0.0411 Operating Cashflow -59086000
Currency USD Time Zone Full Name America/New_York Market Cap 112 M
Is_nasdaq_100 False Zip 01803 Quote Type EQUITY
Industry Biotechnology Long Name Fractyl Health, Inc. Regular Market Day Low 2.19
Held Percent Institutions 0.8881 Current Price 2.33 Address2 Suite 200
Enterprise To Ebitda -1.12 Financial Currency USD Current Ratio 5.58
Gross Margins 46.39 % Industry Disp Biotechnology Number Of Analyst Opinions 2
Country United States Float Shares 17 M Two Hundred Day Average 4.81
Enterprise Value 90 M Price To Sales Trailing12 Months 1155.37 Forward PE -0.9137
Regular Market Volume 315788 Ebitda -80810000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.

The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.

It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients.

Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021.

The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.